[Aggressive myeloma with subcutaneous tumor and pericardial involvement]

R Takahashi1, E Ashihara, T Hirata

  • 1Second Department of Medicine, Kyoto Prefectural University of Medicine.

Insights

This rare multiple myeloma case highlights pericardial effusion. High levels of interleukin-6 (IL-6) in the effusion correlated with myeloma cell proliferation, suggesting IL-6

Area of Science:

  • Hematology
  • Oncology
  • Internal Medicine

Background:

  • Multiple myeloma is a plasma cell malignancy.
  • Extramedullary disease is common but pericardial involvement is rare.

Observation:

  • A 67-year-old male presented with anemia, thrombocytopenia, and renal failure.
  • Bone marrow biopsy revealed lymphoblastoid cell infiltration, diagnosing multiple myeloma (BJ-kappa, stage IIIB).
  • The patient relapsed with subcutaneous tumors and pericardial effusion.

Findings:

  • Myeloma cell invasion into the pericardial space was diagnosed.
  • Interleukin-6 (IL-6) levels in pericardial effusion were significantly elevated (16382 pg/ml).
  • In vitro studies showed myeloma cells from the effusion responded to IL-6.

Implications:

  • This case suggests a strong correlation between high IL-6 levels and myeloma cell proliferation in pericardial effusions.
  • IL-6 may play a critical role in the pathogenesis of myeloma pericardial effusions.
  • Further research into IL-6 targeted therapies for such rare presentations is warranted.